Seoul Ofloxacin Tablets

Adult dosage

○ The usual adult dose is 300～600 mg of ofloxacin daily in 2～3 divided doses. ○ For Hansen's disease, take 400～600 mg of this medicine daily in 2～3 divided doses. In principle, it should be used in combination with other anti-Hansen's disease medicines. Adjust the dose as appropriate according to age and symptoms.

This medication can cause serious side effects such as tendinitis and tendon rupture, peripheral neuropathy, and central nervous system abnormalities; therefore, if symptoms appear, use should be discontinued immediately. In particular, it should not be administered to patients with myasthenia gravis, as symptoms may worsen. This medication should only be used in limited cases such as acute bacterial non-sinusitis, acute bacterial exacerbations of chronic bronchitis and chronic obstructive pulmonary disease, simple urinary tract infections, and acute otitis media. In elderly patients, those with impaired renal function, solid organ transplant recipients, and those using corticosteroids concurrently, the risk of tendon rupture is increased, and co-administration should be avoided. If symptoms of pain, inflammation, or tendon rupture occur, treatment should be stopped immediately and rest should be taken. This medication may exacerbate symptoms due to neuromuscular blocking effects in patients with myasthenia gravis, thus caution is needed. Patients with hypersensitivity to this medication, a history of tendinitis or tendon rupture, individuals under the age of 18, pregnant or breastfeeding women, and those with certain genetic disorders should not use this medication. Patients with severe renal impairment, the elderly, those with mental illness, liver impairment, a history of aortic aneurysm or heart valve disease should be prescribed cautiously, and regular monitoring may be necessary. This medication may cause various side effects such as anaphylactic shock, hypersensitivity reactions, renal and hepatic dysfunction, gastrointestinal issues, blood abnormalities, neurological issues, skin issues, musculoskeletal issues, respiratory and circulatory problems; thus, if any adverse symptoms occur, patients should consult medical professionals immediately. While taking this medication, excessive sun or ultraviolet exposure should be avoided, and if rashes or photosensitivity reactions occur, the administration should be discontinued. Additionally, there is a risk of seizures, so patients with a history of seizures should discuss with healthcare professionals before taking this medication. Patients with diabetes should carefully monitor their blood glucose levels as hypoglycemic disturbances may occur. This medication has the potential to interact with various drugs, so if other medications are being taken, healthcare providers must be informed, especially when combined with anticoagulants, antihypertensives, or antacids. Pregnant or breastfeeding women should not use this medication, and it should not be administered to children and adolescents. The elderly may experience increased drug concentrations due to decreased renal function, thus dose adjustment and caution are necessary. In cases of overdose, medical professionals should be notified immediately and appropriate measures should be taken, and intravenous injections should be administered slowly to reduce side effects such as hypotension. Lastly, this medication should be kept out of the reach of children and should not be transferred to other containers.

• Tendinitis
• tendon rupture
• peripheral neuropathy
• central nervous system effects
• worsening of myasthenia gravis
• anaphylactic shock
• anaphylactic reaction
• rash
• itching
• erythema

This medication should be stored in a sealed container to prevent air and moisture exposure, ideally at room temperature between 1 degree and 30 degrees Celsius. This will help maintain the medication's efficacy for a longer period.

Appearance

White to slightly yellowish round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle